Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label subcutaneous S-811717 (oxycodone) in patients with cancer pain
jRCT2080220763Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oxycodone in cancer pain, sponsored by Shionogi & Co., Ltd.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080220763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220763.